Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
232.30
-1.20
(-0.51%)
At close: February 28 at 5:26:30 PM GMT+1
Key Executives
Key Executives Information Not Available
Alnylam Pharmaceuticals Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Alnylam Pharmaceuticals Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 30, 2025 at 12:30 PM UTC - May 5, 2025 at 12:30 PM UTC
Alnylam Pharmaceuticals Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
APRE Aprea Therapeutics, Inc.
2.5336
+0.14%
RKVTF RAKOVINA THERAPEUTICS INC
0.0920
0.00%
SLXNW Silexion Therapeutics Corp
0.0600
-13.42%
GALT Galectin Therapeutics Inc.
1.5700
+6.08%
RKV.V Rakovina Therapeutics Inc.
0.1400
-12.50%
INKT MiNK Therapeutics, Inc.
8.95
-2.72%
TECX Tectonic Therapeutic, Inc.
25.28
-1.13%
ABSI Absci Corporation
3.8500
-4.70%
SANA Sana Biotechnology, Inc.
2.6100
+0.77%
KZIA Kazia Therapeutics Limited
0.8514
+1.36%